LexDanaLexDanabeta
Inventor

William Robert Carling

Inventor
Bishops Stortford, GB

Overview

55→
Patents
1985–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 55 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
C07DHeterocyclic compounds39%
A61KPreparations for medical, dental or toiletry purposes13%
C07KPeptides5%
C07CAcyclic or carbocyclic compounds2%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution1%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests1%
PatentTitleYear
10,988,474Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response202110,392,382Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response201910,065,992Cyclosporin analogs20189,567,328'Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response'20179,561,259'Cyclosporin analogs'20179,522,890'Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response'20169,493,511'Cyclosporin analogs'20169,422,273'Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response'20169,394,284'Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response'20169,266,927'Cyclosporin A analogs'20169,175,042'Cyclosporin analogs'20159,090,566'Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response'20159,085,567'Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response'20159,035,071'Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response'20158,969,589'Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response'20158,901,159'Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors'20148,859,606'Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response'20148,653,118'Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response'20148,492,424'Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response'20137,485,640'Imidazopyrazinones as GABA-A receptor anxiolytics'20096,960,598'(1,8) naphthyridines as gaba ligands, their pharmaceutical compositions and uses'20056,960,584'Inhibitors of Akt activity'20056,946,461'Imidazolophthalazine derivatives as ligands for GABAA receptors'20056,936,608'Imidazo-triazine derivatives as ligands for GABA receptors'20056,872,720'Pyrazolo-triazine derivatives as ligands for gaba receptors'20056,828,322'Triazolo-pyridazine derivatives as ligands for GABA receptors'20046,699,859'Triazolo-pyridazine derivatives as ligands for GABA receptors'20046,696,444'Imidazo-triazine derivatives as ligands for GABA receptors'20046,630,471'Substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom'20036,617,326'Imidazo-triazine derivatives as ligands for GABA receptors'20036,608,062'Imidazo-triazine derivatives as ligands for GABA receptors'20036,593,325'Pyrido-pyridazine derivatives as ligands for GABA receptors'20036,579,875'Triazolo-pyridazine derivatives as ligands for GABA receptors'20036,500,828'Triazolo-pyridazine derivatives as ligands for gaba receptors'20026,476,030'Pyrazolo-triazine derivatives as ligands for GABA receptors'20026,465,462'Substituted triazolo pyridazine derivatives as inverse agonists of the GABAA5 receptor subtype'20026,448,249'Substituted 1,2,4-triazolo3,4-Aphthalazine derivatives as GABA5 ligands'20026,355,638'Pyrazolo1,5-d1,2,4 triazines for enhancing cognition'20026,313,125'Therapeutically active 1,2,4-triazolo[4.,3-B] pyridazine derivatives as ligands for GABA receptors'20016,310,203'Precursor compounds to substituted 1,2,4-triazolo[3,4,-a]phathalazine GABA alpha 5 ligands'20016,303,597'Triazolo-pyridazine derivatives as ligands for GABA receptors'20016,255,305'Substituted triazolo-pyridazine derivatives as ligands for GABA receptors'20016,200,975'Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as GABA alpha 5 ligands'20015,939,436'Five-membered heteroaromatic compounds as dopamine receptor subtype ligands'19995,763,448'Pyrmidine derivatives'19985,698,573'Imidazolone and oxazolone derivatives as dopamine antagonists'19975,618,812'Benzodiazepine derivatives'19975,614,532'Quinolone derivatives'19975,602,125'Thienodiazepine derivatives as cholecystokinin and gastrin antagonists'19975,475,008'Quinolone derivatives'19955,376,748'Nitroquinolone derivatives'19945,252,584'Hydroxyquinolone derivatives'19935,231,102'Tetrahydroquinoline derivatives useful for neurodegenerative disorders'19934,927,819'Cyclo-octane neuroprotective agents'19904,528,282'Amide derivatives'1985

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1985Based in Macclesfield, GB· patent location history
1990–2009Patents assigned to MERCK SHARP & DOHME (32)· patent assignee history
1990–2021Based in Bishops Stortford, GB· patent location history
2002Based in Bishops Storford, GB· patent location history
2003Based in Harlow, GB· patent location history
2013–2021Patents assigned to ALLERGAN INC (19)· patent assignee history
2013–2014Patents assigned to CARLING WILLIAM R (3)· patent assignee history
2013–2014Patents assigned to MARTOS JOSE L (3)· patent assignee history
2013–2014Patents assigned to WANG JENNY W (3)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME321990–2009
ALLERGAN INC192013–2021
CARLING WILLIAM Rself32013–2014
MARTOS JOSE L32013–2014
WANG JENNY W32013–2014
Locations
LocationPatentsSpan
Bishops Stortford, GB511990–2021
Harlow, GB22003
Bishops Storford, GB12002
Macclesfield, GB11985